COVID-19 coding update: CDC issues extended guidance on how to code COVID-19 cases

Why This Topic Matters

COVID-19 coding guidance changed rapidly and affected diagnosis reporting, symptom capture, exposure encounters, and lab test billing. This article helps readers understand which organizations issued the guidance and which code sets were involved.

Article Sections

1. COVID-19 diagnosis coding update

   Introduces the timing and context of the diagnosis coding update for COVID-19 in the United States. Summarizes the role of federal coding guidance and the transition from interim instructions to a dedicated diagnosis code.

2. Interim diagnosis and manifestation guidance

   Describes the broad interim approach used before the new diagnosis code became effective. Addresses reporting concepts for confirmed illness, associated respiratory conditions, and related manifestations.

3. Exposure and symptom coding guidance

   Covers the general reporting approach for possible exposure, ruled-out exposure, and patients with signs or symptoms without a definitive diagnosis. Discusses the use of encounter and symptom-related coding concepts.

4. New lab test codes

   Summarizes the introduction of new laboratory testing codes from CMS and the AMA. Notes that the article discusses payer-specific lab test reporting and related implementation timing.